Azenta, Inc. (AZTA)
USD 26.44
(-0.36%)
USD 26.44
(-0.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 351.22 Million USD | -0.43% |
| 2022 | 352.73 Million USD | -28.62% |
| 2021 | 494.17 Million USD | 43.03% |
| 2020 | 345.51 Million USD | -8.54% |
| 2019 | 377.76 Million USD | -0.11% |
| 2018 | 378.17 Million USD | 137.87% |
| 2017 | 158.98 Million USD | 20.25% |
| 2016 | 132.21 Million USD | 3.61% |
| 2015 | 127.6 Million USD | -5.58% |
| 2014 | 135.14 Million USD | 29.82% |
| 2013 | 104.1 Million USD | 12.35% |
| 2012 | 92.65 Million USD | -21.49% |
| 2011 | 118.02 Million USD | -8.42% |
| 2010 | 128.87 Million USD | 37.54% |
| 2009 | 93.69 Million USD | -22.71% |
| 2008 | 121.23 Million USD | -21.58% |
| 2007 | 154.59 Million USD | -19.92% |
| 2006 | 193.04 Million USD | -38.36% |
| 2005 | 313.18 Million USD | -12.33% |
| 2004 | 357.22 Million USD | 8.35% |
| 2003 | 329.7 Million USD | -5.47% |
| 2002 | 348.76 Million USD | 25.05% |
| 2001 | 278.9 Million USD | 184.34% |
| 2000 | 98.08 Million USD | 192.8% |
| 1999 | 33.5 Million USD | 74.48% |
| 1998 | 19.2 Million USD | 23.87% |
| 1997 | 15.5 Million USD | 9.93% |
| 1996 | 14.1 Million USD | 41.0% |
| 1995 | 10 Million USD | 20.48% |
| 1994 | 8.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 332.89 Million USD | -2.27% |
| 2024 Q2 | 340.62 Million USD | -10.51% |
| 2024 Q1 | 380.65 Million USD | 8.38% |
| 2023 Q1 | 421.02 Million USD | 19.36% |
| 2023 Q4 | 351.22 Million USD | 1.53% |
| 2023 Q2 | 354.58 Million USD | -15.78% |
| 2023 Q3 | 345.91 Million USD | -2.45% |
| 2023 FY | 351.22 Million USD | -0.43% |
| 2022 Q4 | 352.73 Million USD | 19.6% |
| 2022 FY | 352.73 Million USD | -28.62% |
| 2022 Q1 | 487.51 Million USD | -1.35% |
| 2022 Q2 | 690.62 Million USD | 41.66% |
| 2022 Q3 | 294.93 Million USD | -57.3% |
| 2021 Q4 | 494.17 Million USD | 8.51% |
| 2021 Q1 | 362.57 Million USD | 4.94% |
| 2021 FY | 494.17 Million USD | 43.03% |
| 2021 Q2 | 398.07 Million USD | 9.79% |
| 2021 Q3 | 455.42 Million USD | 14.41% |
| 2020 Q1 | 400.26 Million USD | 5.96% |
| 2020 Q2 | 318.19 Million USD | -20.5% |
| 2020 Q3 | 329.06 Million USD | 3.41% |
| 2020 Q4 | 345.51 Million USD | 5.0% |
| 2020 FY | 345.51 Million USD | -8.54% |
| 2019 Q1 | 766.53 Million USD | 102.69% |
| 2019 Q4 | 377.76 Million USD | -49.95% |
| 2019 FY | 377.76 Million USD | -0.11% |
| 2019 Q3 | 754.73 Million USD | -0.43% |
| 2019 Q2 | 757.96 Million USD | -1.12% |
| 2018 Q1 | 361.67 Million USD | 127.49% |
| 2018 FY | 378.17 Million USD | 137.87% |
| 2018 Q4 | 378.17 Million USD | -0.04% |
| 2018 Q3 | 378.33 Million USD | 2.61% |
| 2018 Q2 | 368.7 Million USD | 1.95% |
| 2017 Q4 | 158.98 Million USD | 1.26% |
| 2017 FY | 158.98 Million USD | 20.25% |
| 2017 Q1 | 139.4 Million USD | 5.44% |
| 2017 Q2 | 151.56 Million USD | 8.72% |
| 2017 Q3 | 156.99 Million USD | 3.59% |
| 2016 Q2 | 146.44 Million USD | 13.7% |
| 2016 Q4 | 132.21 Million USD | -5.06% |
| 2016 FY | 132.21 Million USD | 3.61% |
| 2016 Q1 | 128.8 Million USD | 0.93% |
| 2016 Q3 | 139.26 Million USD | -4.9% |
| 2015 Q1 | 126.53 Million USD | -6.38% |
| 2015 Q2 | 128.12 Million USD | 1.26% |
| 2015 Q3 | 139.14 Million USD | 8.6% |
| 2015 Q4 | 127.6 Million USD | -8.29% |
| 2015 FY | 127.6 Million USD | -5.58% |
| 2014 FY | 135.14 Million USD | 29.82% |
| 2014 Q4 | 135.14 Million USD | -1.94% |
| 2014 Q1 | 97.16 Million USD | -6.67% |
| 2014 Q2 | 132.82 Million USD | 36.69% |
| 2014 Q3 | 137.82 Million USD | 3.76% |
| 2013 Q3 | 96.59 Million USD | 2.23% |
| 2013 Q2 | 94.48 Million USD | 7.94% |
| 2013 Q1 | 87.54 Million USD | -5.52% |
| 2013 FY | 104.1 Million USD | 12.35% |
| 2013 Q4 | 104.1 Million USD | 7.77% |
| 2012 Q1 | 107.05 Million USD | -9.3% |
| 2012 Q2 | 114.39 Million USD | 6.86% |
| 2012 Q3 | 119.77 Million USD | 4.7% |
| 2012 Q4 | 92.65 Million USD | -22.64% |
| 2012 FY | 92.65 Million USD | -21.49% |
| 2011 Q1 | 122.7 Million USD | -4.78% |
| 2011 FY | 118.02 Million USD | -8.42% |
| 2011 Q3 | 112.38 Million USD | -7.0% |
| 2011 Q2 | 120.84 Million USD | -1.52% |
| 2011 Q4 | 118.02 Million USD | 5.01% |
| 2010 Q1 | 109.86 Million USD | 17.25% |
| 2010 FY | 128.87 Million USD | 37.54% |
| 2010 Q4 | 128.87 Million USD | -4.41% |
| 2010 Q3 | 134.81 Million USD | 3.95% |
| 2010 Q2 | 129.69 Million USD | 18.05% |
| 2009 FY | 93.69 Million USD | -22.71% |
| 2009 Q1 | 103.21 Million USD | -14.87% |
| 2009 Q2 | 84.98 Million USD | -17.66% |
| 2009 Q3 | 84.36 Million USD | -0.73% |
| 2009 Q4 | 93.69 Million USD | 11.06% |
| 2008 Q1 | 126.02 Million USD | -18.48% |
| 2008 Q2 | 136.01 Million USD | 7.93% |
| 2008 Q3 | 124.46 Million USD | -8.49% |
| 2008 Q4 | 121.23 Million USD | -2.6% |
| 2008 FY | 121.23 Million USD | -21.58% |
| 2007 Q2 | 155.97 Million USD | -10.61% |
| 2007 Q1 | 174.48 Million USD | -9.62% |
| 2007 FY | 154.59 Million USD | -19.92% |
| 2007 Q4 | 154.59 Million USD | 3.65% |
| 2007 Q3 | 149.15 Million USD | -4.37% |
| 2006 Q4 | 193.04 Million USD | -45.26% |
| 2006 Q2 | 351.6 Million USD | 5.66% |
| 2006 Q1 | 332.76 Million USD | 6.25% |
| 2006 FY | 193.04 Million USD | -38.36% |
| 2006 Q3 | 352.66 Million USD | 0.3% |
| 2005 Q1 | 333.2 Million USD | -6.72% |
| 2005 Q2 | 329.1 Million USD | -1.23% |
| 2005 Q3 | 323.26 Million USD | -1.77% |
| 2005 FY | 313.18 Million USD | -12.33% |
| 2005 Q4 | 313.18 Million USD | -3.12% |
| 2004 Q2 | 359.38 Million USD | 9.66% |
| 2004 Q4 | 357.22 Million USD | 0.91% |
| 2004 Q3 | 354.01 Million USD | -1.49% |
| 2004 FY | 357.22 Million USD | 8.35% |
| 2004 Q1 | 327.72 Million USD | -0.6% |
| 2003 Q3 | 340.85 Million USD | 1.13% |
| 2003 FY | 329.7 Million USD | -5.47% |
| 2003 Q4 | 329.7 Million USD | -3.27% |
| 2003 Q2 | 337.04 Million USD | -2.85% |
| 2003 Q1 | 346.92 Million USD | -0.53% |
| 2002 Q2 | 280.64 Million USD | -2.11% |
| 2002 Q1 | 286.68 Million USD | 2.79% |
| 2002 Q3 | 423.71 Million USD | 50.98% |
| 2002 Q4 | 348.76 Million USD | -17.69% |
| 2002 FY | 348.76 Million USD | 25.05% |
| 2001 Q3 | 287.8 Million USD | 175.73% |
| 2001 Q4 | 278.9 Million USD | -3.1% |
| 2001 Q2 | 104.37 Million USD | -0.98% |
| 2001 Q1 | 105.41 Million USD | 7.47% |
| 2001 FY | 278.9 Million USD | 184.34% |
| 2000 Q2 | 78.51 Million USD | 110.49% |
| 2000 FY | 98.08 Million USD | 192.8% |
| 2000 Q1 | 37.3 Million USD | 11.34% |
| 2000 Q4 | 98.08 Million USD | 10.7% |
| 2000 Q3 | 88.6 Million USD | 12.86% |
| 1999 Q2 | 18.4 Million USD | 15.72% |
| 1999 Q1 | 15.9 Million USD | -17.19% |
| 1999 FY | 33.5 Million USD | 74.48% |
| 1999 Q4 | 33.5 Million USD | 27.38% |
| 1999 Q3 | 26.3 Million USD | 42.93% |
| 1998 Q4 | 19.2 Million USD | 58.68% |
| 1998 Q1 | 15 Million USD | -3.23% |
| 1998 FY | 19.2 Million USD | 23.87% |
| 1998 Q2 | 15.4 Million USD | 2.67% |
| 1998 Q3 | 12.1 Million USD | -21.43% |
| 1997 Q3 | 23.7 Million USD | 36.21% |
| 1997 Q2 | 17.4 Million USD | 31.82% |
| 1997 FY | 15.5 Million USD | 9.93% |
| 1997 Q1 | 13.2 Million USD | -6.38% |
| 1997 Q4 | 15.5 Million USD | -34.6% |
| 1996 FY | 14.1 Million USD | 41.0% |
| 1996 Q2 | 13.6 Million USD | 0.0% |
| 1996 Q4 | 14.1 Million USD | -4.73% |
| 1996 Q3 | 14.8 Million USD | 8.82% |
| 1995 Q4 | 10 Million USD | 0.0% |
| 1995 FY | 10 Million USD | 20.48% |
| 1994 FY | 8.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -177.427% |
| AngioDynamics, Inc. | 112.08 Million USD | -213.351% |
| AtriCure, Inc. | 147.76 Million USD | -137.69% |
| Avinger, Inc. | 19.97 Million USD | -1658.562% |
| BioLife Solutions, Inc. | 75.05 Million USD | -367.975% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 91.45% |
| Daxor Corporation | 858.75 Thousand USD | -40798.6% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -2053.139% |
| Femasys Inc. | 9.4 Million USD | -3635.097% |
| GlucoTrack, Inc. | 1.7 Million USD | -20463.232% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -446.289% |
| Hologic, Inc. | 4.02 Billion USD | 91.276% |
| ICU Medical, Inc. | 2.25 Billion USD | 84.425% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 82.819% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -4232.198% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -618.565% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -53120.312% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -53120.312% |
| Masimo Corporation | 1.67 Billion USD | 79.053% |
| Microbot Medical Inc. | 3.82 Million USD | -9079.822% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -1300.541% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 68.732% |
| Nephros, Inc. | 3.5 Million USD | -9926.263% |
| NovoCure Limited | 783.63 Million USD | 55.181% |
| NEXGEL, Inc. | 4.78 Million USD | -7233.89% |
| NEXGEL, Inc. | 4.78 Million USD | -7233.89% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -306.218% |
| OraSure Technologies, Inc. | 52.17 Million USD | -573.171% |
| Pro-Dex, Inc. | 23.34 Million USD | -1404.605% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -2035.855% |
| Predictive Oncology Inc. | 6.14 Million USD | -5615.105% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -5031.205% |
| QuidelOrtho Corporation | 3.55 Billion USD | 90.127% |
| Repligen Corporation | 853.2 Million USD | 58.835% |
| Sanara MedTech Inc. | 29.28 Million USD | -1099.394% |
| STAAR Surgical Company | 102.73 Million USD | -241.86% |
| Sharps Technology, Inc. | 3.85 Million USD | -9010.808% |
| Utah Medical Products, Inc. | 7.14 Million USD | -4815.605% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 91.383% |
| Jin Medical International Ltd. | 8.92 Million USD | -3835.527% |